Diabetes
How does TXNIP control muscle glucose uptake?
Open access · cc by · source: Europe PMC
Human studies show TXNIP is repressed by insulin, induced by glucose, elevated in dysglycaemia, and can inhibit peripheral glucose uptake.
Study at a glance
- Design
- Human experiment — Euglycemic-hyperinsulinemic clamp gene-expression studies plus genetics and cellular work
- N
- Studies A/B: six nondiabetic volunteers each; study C: 96 young nondiabetic twins; plus adipocyte culture — no single primary analytic N
- Population
- Nondiabetic volunteers and twins undergoing clamp muscle biopsies; cellular validation
- Outcome
- Insulin regulation of TXNIP and relation to insulin-stimulated glucose uptake
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
TXNIP (with BCL6) was consistently repressed by insulin; TXNIP is reciprocally regulated by insulin and glucose, elevated in T2DM/prediabetes, inversely related to insulin-stimulated glucose uptake in non-diabetic people, and can inhibit glucose uptake when elevated.
Methodology
Investigators combined euglycemic-hyperinsulinemic clamps, muscle gene expression, genetics, and cellular work to identify insulin-responsive genes and test TXNIP’s role in human glucose metabolism.
Limitations
TXNIP genetic variation did not explain inherited T2DM risk here; this is mechanistic physiology, not a drug trial.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
TXNIP rises with impaired glucose handling and tracks lower muscle glucose uptake.
In human muscle physiology work, TXNIP is reciprocally regulated by insulin and glucose, elevated in T2DM/prediabetes, and inversely related to glucose uptake—pointing to a molecular brake on peripheral glucose disposal.
Evidence for the claim as stated.
Insulin barely raises muscle ATP synthesis in insulin-resistant offspring of parents with diabetes.
In insulin-resistant offspring of parents with type 2 diabetes, insulin raised muscle ATP synthesis flux only ~5% versus ~90% in controls—evidence of early mitochondrial dysfunction before overt diabetes.
Scope note — different molecular focus — TXNIP/glucose uptake, not ATP flux
Limits the claim's scope: a different population, assay, or outcome.
A type 1 diabetes self-management app plus clinician feedback can lower HbA1c versus usual care.
In a type 1 diabetes trial, a self-management app plus clinician feedback was associated with a significant HbA1c decrease versus usual care; usage frequency did not clearly mediate the HbA1c change.
Scope note — different question — molecular physiology, not digital self-management
Limits the claim's scope: a different population, assay, or outcome.
Muscle mechanism studies, night-shift incidence, GDM sequelae, T2D complication associations, and a T1D app trial all sit under diabetes care but answer different estimands. They are complementary scopes, not interchangeable results.
Evidence for the claim as stated.
TXNIP rises with impaired glucose handling and tracks lower muscle glucose uptake.
In human muscle physiology work, TXNIP is reciprocally regulated by insulin and glucose, elevated in T2DM/prediabetes, and inversely related to insulin-stimulated glucose uptake—pointing to a molecular brake on peripheral disposal.
Evidence for the claim as stated.
Insulin barely raises muscle ATP synthesis in insulin-resistant offspring of parents with diabetes.
In insulin-resistant offspring of parents with type 2 diabetes, insulin raised muscle ATP synthesis flux only ~5% versus ~90% in controls—evidence of early mitochondrial dysfunction before overt diabetes.
Scope note — different molecular readout — TXNIP expression vs 31P-MRS ATP flux
Limits the claim's scope: a different population, assay, or outcome.
Longer rotating night-shift work associates with higher type 2 diabetes risk in nurses.
In Nurses’ Health Study I and II, longer rotating night-shift duration was associated with higher incident type 2 diabetes risk (age-adjusted HRs rising with years of shift work), linking circadian disruption exposures to later diabetes incidence.
Scope note — different level — occupational epidemiology, not muscle molecular physiology
Limits the claim's scope: a different population, assay, or outcome.
Muscle TXNIP/ATP-flux studies explain peripheral disposal defects in small physiology samples; night-shift cohorts estimate diabetes incidence at population scale. They cohere as levels of analysis, not as interchangeable effect sizes.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Muscle mechanism studies, night-shift incidence, GDM sequelae, T2D complication associations, and a T1D app trial all sit under diabetes care but answer different estimands. They are complementary scopes, not interchangeable results.
- Supports · Night shifts and type 2 diabetes risk
- Supports · GDM associated with higher later diabetes and heart risks
- Supports · Muscle ATP defect in diabetes-prone offspring
- Supports · Glucose Buddy app associated with improved type 1 HbA1c in a trial
- Supports · Healthier habits associated with lower T2D microvascular complication risk
Muscle TXNIP/ATP-flux studies explain peripheral disposal defects in small physiology samples; night-shift cohorts estimate diabetes incidence at population scale. They cohere as levels of analysis, not as interchangeable effect sizes.
- Supports · Night shifts and type 2 diabetes risk
History
When this study was placed
Dated entries from the concept change log — when this paper was added or removed as support, challenge, or qualifier on a claim.
Placed as a scope qualifier on Diabetes Care
In insulin-resistant offspring of parents with type 2 diabetes, insulin raised muscle ATP synthesis flux only ~5% versus ~90% in controls—evidence of early mitochondrial dysfunction before overt diabetes.
Placed as a scope qualifier on Diabetes Care
In a type 1 diabetes trial, a self-management app plus clinician feedback was associated with a significant HbA1c decrease versus usual care; usage frequency did not clearly mediate the HbA1c change.
Related papers in this topic
Same topic cluster — not a recommendation engine.